-The Hindu There is at last some clarity on the politics of the anti-corruption movements. Baba Ramdev’s dramatic call for Congress- hatao and the ‘political turn’ of the Anna movement have confirmed that a movement aimed at rooting out corruption cannot defer a direct encounter with party politics for very long. The manner in which both decisions were announced left something to be desired. The announcement by ‘Team Anna’ invited serious...
More »SEARCH RESULT
‘Buffer zones in tiger reserves will violate livelihood rights’-Aarti Dhar
-The Hindu Communist Party of India MP D. Raja has expressed concern at the State governments notifying buffer zones in tiger reserves. He argued that the move would violate the livelihood rights of lakhs of people. In a letter, he asked Prime Minister Manmohan Singh to halt the exercise and ensure that the Supreme Court is informed of the actual legal and ground positions. Failure to do so will amount to violation...
More »CAG Vinod Rai's service records and dossier missing
-IANS The service records of Comptroller and Auditor General (CAG) Vinod Rai "are not traceable", the Department of Personnel and Training (DoPT) has revealed in response to a Right to Information (RTI) application. Lucknow activist Arvind Shukla had filed the RTI application last month, seeking details about the most powerful accountant of the country, who has gained renown as a vigilant anti-corruption watchdog and who is once again in the spotlight after...
More »Maharashtra leads in drug trial-related deaths-Mahim Pratap Singh
-The Hindu Maharashtra recorded the maximum number of deaths due to serious adverse events (SAEs) during drug trials, while Madhya Pradesh saw the least number of such deaths. According to data disclosed by the Drug Controller-General of India, during the 49-month period (January 2008-January 2012), the country recorded 2,061 drug trial-related deaths. But data has been given only for 1,603 of the 2,061 deaths. Maharashtra recorded the maximum number of 268 deaths to...
More »CDSCO drafting new norms for financial compensation-Mahim Pratap Singh
-The Hindu In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases. The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000. This makes 2011 only the second year, for which data are...
More »